New York, NY -- (SBWIRE) -- 12/12/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Green Innovations Ltd (OTC:GNIN), Arca Biopharma Inc (NASDAQ:ABIO), Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Altria Group Inc (NYSE:MO)
Green Innovations Ltd (OTC:GNIN) showed a volume of 21.66 million shares by the end of last trade whereas the average volume of the stock remained 3.14 million shares. The stock opened the session at $1.73 but then moved to $1.83. At that price, the stock showed a positive performance of 6.40%. Globalstar, Inc. (Globalstar) is a provider of mobile voice and data communications services globally via satellite. Globalstar’s satellite communications business, by providing critical mobile communications to the Company's subscribers, serves principally recreation and personal; government; public safety and disaster relief; oil and gas; maritime and fishing; natural resources, mining and forestry; construction; utilities and transportation.
Will GNIN Continue To Move Higher? Find Out Here
Arca Biopharma Inc (NASDAQ:ABIO) opened the session at $1.51 and closed the session at $1.52. The stock showed a positive performance of 2.01% in previous trading session. Traded with volume of 1.93 million shares in the prior session and the average volume of the stock remained 1.59 million shares. ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company's principal focus is developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA's lead product candidate is Gencaro TM (bucindolol hydrochloride), a pharmacologically beta-blocker and mild vasodilator being developed for the treatment of chronic heart failure (HF).
For How Long ABIO will fight for Profitability? Read This Trend Analysis report
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) opened the session at $3.46 and closed the session at $3.01. The stock showed a negative performance of -29.84% in previous trading session. Traded with volume of 14.28 million shares in the prior session and the average volume of the stock remained 1.72 million shares. The beta of the stock remained 1.72. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas.
Why Should Investors Buy AVNR After the Recent Fall? Just Go Here and Find Out
Altria Group Inc (NYSE:MO) the stock advanced 0.94% and finished the session at $37.67. Traded with volume of 9.83 million shares in the prior session and the average volume of the stock remained 6.78 million shares. The beta of the stock remained 0.39. Altria Group, Inc. is a holding company. At December 31, 2012, Altria Group, Inc.'s direct and indirect wholly owned subsidiaries included Philip Morris USA Inc. (PM USA), which is engaged in the manufacture and sale of cigarettes and certain smokeless products in the United States; John Middleton Co.
Will MO Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)